Live from the NIH registry
Studies recruiting near Dayton right now
Top 25 of 306 recruiting studies, sorted by proximity — each links to its official registry page
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Generalized Myasthenia Gravis
N/A
Observational 500 participants sought
Clinical Trial Site — Dayton, Ohio (1.6 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain Tumor, Recurrent, Brain Tumor
N/A
Observational 600 participants sought
Kettering Health — Kettering, Ohio (6.5 mi)
· Sponsor: GT Medical Technologies, Inc.
A Registry of Cardiac PET and CardioFlux Magnetocardiography in Patients With Suspected Coronary Ischemia.
Coronary; Ischemic
N/A
Observational 300 participants sought
Kettering Health — Kettering, Ohio (6.5 mi)
· Sponsor: Genetesis Inc.
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Ovarian Cancer, Fallopian Tube Cancer
Phase 2
Interventional 270 participants sought
304 — Centerville, Ohio (10.7 mi)
· Sponsor: Corcept Therapeutics
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Non-alcoholic Fatty Liver Disease
Phase 3
Interventional 1,250 participants sought
GSK Investigational Site — Springboro, Ohio (15.9 mi)
· Sponsor: GlaxoSmithKline
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Miami Valley Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: NRG Oncology
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,900 participants sought
Dayton Physician LLC - Englewood — Dayton, Ohio (1.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Crohn's Disease
Phase 3
Interventional 120 participants sought
The Children's Medical Center of Dayton — Dayton, Ohio (1.6 mi)
· Sponsor: Janssen Research & Development, LLC
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age
Chickenpox
Phase 3
Interventional 911 participants sought
GSK Investigational Site — Dayton, Ohio (1.6 mi)
· Sponsor: GlaxoSmithKline
Testing Use of Topical Imipramine in Reducing Ultraviolet B Induced Microvesicle Particle Release in Photosensitive Subjects
Photosensitivity, Microvesicle Particle
Phase 1
Interventional 40 participants sought
Wright State Physicians — Fairborn, Ohio (10.0 mi)
· Sponsor: Wright State University
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Dayton Children's Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: National Cancer Institute (NCI)
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis
Phase 2
Interventional 48 participants sought
Dayton Children's Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Centerville, OH Investigative Site 10119 — Centerville, Ohio (10.7 mi)
· Sponsor: Colorado Prevention Center
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
Palmoplantar Pustulosis
Phase 3
Interventional 320 participants sought
Ppp001 50202 — Fairborn, Ohio (10.0 mi)
· Sponsor: UCB Biopharma SRL
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Schizophrenia
N/A
Observational 1,500 participants sought
Local Institution - 0031 — Mason, Ohio (29.6 mi)
· Sponsor: Bristol-Myers Squibb
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
Diabetes Mellitus, Type 2
Phase 2
Interventional 270 participants sought
Providence Center for Clinical Research — Dayton, Ohio (1.6 mi)
· Sponsor: Novo Nordisk A/S
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Hematopoietic and Lymphoid Cell Neoplasm, Immune System Disorder
N/A
Observational 2,240 participants sought
Miami Valley Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Stepped Approach to Reducing Risk of Suicide in Primary Care
Suicidal Ideation, Suicide, Attempted
N/A
Interventional 2,572 participants sought
Dayton Children's Hospital - Hope Center — Dayton, Ohio (1.6 mi)
· Sponsor: Cynthia Fontanella
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Springboro, Ohio (15.9 mi)
· Sponsor: Akero Therapeutics, Inc
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
Non-Muscle Invasive Bladder Neoplasms
Phase 3
Interventional 220 participants sought
Dayton Physicians Network Urology — Centerville, Ohio (10.7 mi)
· Sponsor: Janssen Research & Development, LLC
A Study of COVID-19 Vaccine(s) in Children and Adults
COVID-19 Vaccines
Phase 3
Interventional 700 participants sought
Dayton Clinical Research — Dayton, Ohio (1.6 mi)
· Sponsor: BioNTech SE
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Phase 3
Interventional 1,295 participants sought
Premier Blood and Cancer Center — Dayton, Ohio (1.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Cervical Cancer
Phase 4
Interventional 100 participants sought
Kettering Health Cancer Center — Kettering, Ohio (6.5 mi)
· Sponsor: Pfizer
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Alopecia Areata
Phase 3
Interventional 355 participants sought
Dermatologists Of Southwest Ohio — Mason, Ohio (29.6 mi)
· Sponsor: Sun Pharmaceutical Industries, Inc.
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — Huber Heights, Ohio (5.9 mi)
· Sponsor: Axsome Therapeutics, Inc.